MedTrace Logo

Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease

NCT02193048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2024-05-02

No results posted yet for this study

Summary

The purpose of this study is to prospectively evaluate a scoring system to predict a mild course of disease in patients newly diagnosed with Crohn's disease.

Conditions

Interventions

OTHER

This study will evaluate a new clinical scoring system in patients receiving routine treatment

Treatment for Crohn's disease will be performed routinely based on the treating physicians clinical determination and patients' needs.

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Global Clinical Compliance · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02193048 on ClinicalTrials.gov